#USA #London #Drug Development #Clarivate #Cortellis

Clarivate Enhances Cortellis with Advanced Agentic AI

In a significant move to propel drug development forward, Clarivate Plc has unveiled the expansion of its agentic AI capabilities across the Cortellis suite. This advanced integration is set to empower life sciences organizations by transforming complex data into actionable intelligence, accelerating research and decision-making across the drug development lifecycle.

The Landscape of Life Sciences Development

Life sciences, which encompasses biotechnology and pharmaceutical sectors, often operates within challenging environments marked by intricate data requirements and stringent regulatory demands. To navigate this landscape effectively, researchers require robust tools that allow them to swiftly interpret multifaceted information and develop strategic insights. Clarivate, a recognized leader in providing transformative intelligence, aims to bridge this gap with its Cortellis offerings.

Unveiling New AI Capabilities

The newly enhanced Cortellis suite serves as a powerful ally for research and development (R&D) teams. By embedding AI directly within existing workflows, researchers can significantly reduce the manual efforts typically involved in data handling, enabling them to focus on high-value scientific tasks. Here are the key enhancements that promise to streamline various aspects of drug development:

1. Accelerating Discovery Decisions

With the introduction of innovations in Cortellis Drug Discovery Intelligence, research teams can now engage with complex drug data through natural language processing. This capability allows quick evaluations of therapeutic landscapes, aiding in the comparison of various compounds and prioritizing the most promising opportunities. Ultimately, this reduction in time spent on data gathering allows scientists to concentrate their expertise where it matters most - on advancing pivotal drug candidates through the development pipeline.

2. Enhancing Safety Assessment

Cortellis’ enhanced OFF-X feature introduces multi-agent intelligence, which is instrumental in improving safety assessment processes. By surfacing potential liabilities earlier and synthesizing evidence more efficiently, this tool facilitates a more proactive evaluation of risks throughout the development lifecycle and in post-market scenarios. Such improvements promise to bolster safety protocols and enhance overall productivity in drug assessment practices.

3. Strengthening Competitive Strategy

Furthermore, the introduction of new agentic workflows in Cortellis Competitive Intelligence transforms how strategy and business development professionals monitor shifting market dynamics. Previously time-consuming analyses that could span several weeks are now converted into actionable insights within hours, equipping teams to swiftly adapt to competitive pressures and identify external growth opportunities.

Bridging Insight and Action

As Anne Lecocq, Senior Vice President and General Manager at Clarivate, articulated, the essence of success in modern R&D hinges on the ability to swiftly translate complex data into decisive actions. The Cortellis platform, now enhanced with agentic AI, marks a transition from mere insight delivery to comprehensive workflow execution. This transformation allows researchers to operate with greater precision in high-stakes environments, thereby minimizing friction in decision-making processes.

Powered by proprietary data and expert curation, the Cortellis system stands as a quintessential example of how AI can augment human expertise in the R&D lifecycle, fostering a more collaborative ecosystem that prioritizes intelligent action. This initiative not only seeks to expedite drug development but also aims to improve outcomes for patients and healthcare systems globally.

Conclusion

In conclusion, Clarivate's expansion of agentic AI across Cortellis represents a groundbreaking advancement for the life sciences industry. By integrating artificial intelligence more deeply into R&D workflows, Clarivate is not merely enhancing efficiency; it is fundamentally reshaping how organizations approach drug development to deliver life-saving therapies more swiftly and reliably. For more information about how Cortellis combines trusted intelligence and agentic AI to expedite decision-making, please visit their official site.